Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -23.790% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) COC(=O)c1cc(S(=O)(=O)N2CCN(c3cc(C)ccc3C)CC2)c[nH]1
b.) Cc1csc(NC(=O)CSc2nnc(-c3ccncc3)o2)n1
Answer: a. COC(=O)c1cc(S(=O)(=O)N2CCN(c3cc(C)ccc3C)CC2)c[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1cc(S(=O)(=O)N2CCN(c3cc(C)ccc3C)CC2)c[nH]1
COC(=O)c1cc(S(=O)(=O)N2CCN(c3cc(C)ccc3C)CC2)c[nH]1
methyl 4-[4-(2,5-dimethylphenyl)piperazin-1-yl]sulfonyl-1H-pyrrole-2-carboxylate